The Pilot Project Program (PPP) is an integral component of the CTEHR, supporting the mission of the Center by providing funding for cutting edge environmental health research that promotes basic science and its translational applications. This Program will support early-stage projects with the potential to advance EHS research, and enhance the human health impact of research being conducted in the Early Life Exposures, Microbiome, Chronic Disease, Metabolism and Enabling Technologies Thematic Focus Areas of the Center. The PPP has also been designed to promote utilization of the Facility Cores and enhance COEC activities. Directors of the PPP will coordinate the distribution of Program announcements, development of grant review criteria, receipt of applications, and in concert with the Internal Advisory Committee, selection and contact of external reviewers, ranking of individual projects and final recommendations for awards to the CTEHR Director.
The Specific Aims of the Pilot Project Program are:
Aim 1. Support collaborative inter-institutional projects to enhance EHS research, with a focus on research relevant to the Thematic Focus Areas of the Center.
Aim 2. Enhance the potential for junior investigators to obtain external funding for EHS research by providing support for acquisition of Preliminary Data for grant proposals Aim 3. Promote the development of new and innovative exploratory projects (?high-risk, high-gain?) that have the potential to attract external grant support.
Aim 4. Incentivize interdisciplinary research collaborations to tackle complex environmental health research problems and to attract new members to the CTEHR. The accomplishment of proposed Aims will not only result in development of new collaborations and attract new investigators to environmental health research, but also lead to successful external funding for CETHR investigators.
PROGRAM NARRATIVE - PILOT PROJECT PROGRAM (PPP) The Pilot Project Program will serve to enhance the goals of the CTEHR and the NIEHS by providing funding opportunities for exploratory research, with an emphasis on junior investigators, collaborations and high-risk, high-gain research. With the guidance of the Executive Committee the PPP will coordinate the complete spectrum of activities required for a grant program ranging from announcement of this research grant opportunity to a timely review and funding decision. Thus the PPP will play a major role in enhancing and expanding environmental health research and collaborations at Texas A&M and the Texas Medical Center.
|Luo, Yu-Syuan; Furuya, Shinji; Chiu, Weihsueh et al. (2018) Characterization of inter-tissue and inter-strain variability of TCE glutathione conjugation metabolites DCVG, DCVC, and NAcDCVC in the mouse. J Toxicol Environ Health A 81:37-52|
|Jonker, Renate; Deutz, Nicolaas E P; Schols, Annemie M W J et al. (2018) Whole body protein anabolism in COPD patients and healthy older adults is not enhanced by adding either carbohydrates or leucine to a serving of protein. Clin Nutr :|
|Pogribny, Igor P; Dreval, Kostiantyn; Kindrat, Iryna et al. (2018) Epigenetically mediated inhibition of S-adenosylhomocysteine hydrolase and the associated dysregulation of 1-carbon metabolism in nonalcoholic steatohepatitis and hepatocellular carcinoma. FASEB J 32:1591-1601|
|Jonker, Renate; Deutz, Nicolaas E P; Ligthart-Melis, Gerdien C et al. (2018) Preserved anabolic threshold and capacity as estimated by a novel stable tracer approach suggests no anabolic resistance or increased requirements in weight stable COPD patients. Clin Nutr :|
|Deutz, Nicolaas E P; Thaden, John J; Ten Have, Gabriella A M et al. (2018) Metabolic phenotyping using kinetic measurements in young and older healthy adults. Metabolism 78:167-178|
|Lacey, Alexandra; Hedrick, Erik; Cheng, Yating et al. (2018) Interleukin-24 (IL24) Is Suppressed by PAX3-FOXO1 and Is a Novel Therapy for Rhabdomyosarcoma. Mol Cancer Ther 17:2756-2766|
|Fuentes, Natividad R; Kim, Eunjoo; Fan, Yang-Yi et al. (2018) Omega-3 fatty acids, membrane remodeling and cancer prevention. Mol Aspects Med 64:79-91|
|Engelen, Mariëlle P K J; Deutz, Nicolaas E P (2018) Is ?-hydroxy ?-methylbutyrate an effective anabolic agent to improve outcome in older diseased populations? Curr Opin Clin Nutr Metab Care 21:207-213|
|Prado, Carla M; Purcell, Sarah A; Alish, Carolyn et al. (2018) Implications of low muscle mass across the continuum of care: a narrative review. Ann Med :1-19|
|Hedrick, Erik; Mohankumar, Kumaravel; Safe, Stephen (2018) TGF?-Induced Lung Cancer Cell Migration Is NR4A1-Dependent. Mol Cancer Res 16:1991-2002|
Showing the most recent 10 out of 166 publications